Production Scanners
PRODUCTS
-
Powerful tools for characterizing protein-protein interactions, structural stability, and formulation compatibility.
-
At Applied StemCell, we specialize in producing high-quality differentiated cells from well-characterized normal iPSCs. Our cells offer the biorelevance of primary cells while eliminating the challenges associated with sourcing and variability across batches.
-
PHCbi brand’s 8.1 cu.ft (230 L) Cell-IQ series CO₂ incubator features a patented Direct Heat and Air Jacket system, dual IR sensor, SafeCell™ UV, and inCu-saFe® interior to helps ensure precise temperature, CO₂ levels, and contamination control. A high-speed H₂O₂ vapor decontamination cycle completes in under three hours, supporting rapid turnaround in high-throughput labs. This stackable, medium-capacity unit is ideal for scaling up cell culture workflows and integrating with lab automation systems.
-
Unrivalled nuclear containment gloveboxes to NQA-1 Quality Standards in accordance with the ASME 2008:2009 Addenda.
-
The MadAFM sample scanning atomic force microscope is powered by industry-leading closed-loop nanopositioners to ensure high-resolution performance, true decoupled motion, and virtually undetectable out-of-plane motion.
WHITE PAPERS AND CASE STUDIES
-
Gene And Cell Therapy: Planning For Manufacturing Success Early
As gene therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations, explore how to optimize plasmid production and reach patients with efficiency.
-
A Partnership To Deliver Excellence In Antibody Discovery And Production
Explore the partnership that assisted FairJourney Biologics in methodically handling 30 to 40 different production projects concurrently.
-
How Light Cure CIPP Helps This Family Business Expand
Discover why a Connecticut-based contractor describes SpeedyLight+ light curing system for CIPP as a "game changer" for their pipe lining division.
-
How A Top 5 Pharma Realized $20M In Annual Savings
A top 5 pharmaceutical company faced a threat to their flagship product and aimed to enhance profitability despite a high COGS. Learn about the solution that played a key role in overcoming this hurdle.
-
Development And Optimization Of Suspension-Adapted 293T Cell Line
Learn how an adapted cell line can reduce costs and improve scalability in the production of lentiviral vectors for CGTs and examine its potential to produce GMP-grade lentiviral vectors.
-
The Value Of Engaging A Single CDMO For Comprehensive Biologics Services
By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.
-
Solving Imminent Regulatory Challenges With Single-Use Technologies
Here, we explain how companies using mRNA vaccine technology can address compliance challenges through single-use technologies.
-
How To Get Products To Patients Faster With A Connected QMS
BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.
-
Super Short Activated CAR-T Process
Experience the benefits of faster, more effective CAR-T cell production with this innovative three-day short-cycle process, designed to enhance patient treatment outcomes while reducing costs.
-
Comprehensive Pathway To Seamless Scale-Up Of mRNA DP Manufacturing
An integrated approach to mRNA drug product manufacturing helps to accelerate drug development, mitigate risks, and ultimately deliver life-changing therapies to patients.
-
Flexible Fill/Finish Solutions To Bridge The Clinical-To-Commercial Gap
As biopharma complexity grows, flexible CDMOs are essential for navigating evolving fill/finish needs, accelerated timelines, and regulatory uncertainty with agility and expertise.
-
Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges
Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.
NEWS
-
Clariant SynDane Catalyst Achieves Performance Milestones At Wanhua Maleic Anhydride Plant9/29/2025
Clariant, a sustainability-focused specialty chemical company, today announced the solid performance of its SynDane 3142 LA catalyst at Wanhua Chemical's maleic anhydride plant in Yantai, Shandong province, China.
-
Quadient Launches New Cloud-Based Application To Empower Small Businesses In Their Mail Management Processes7/4/2024
Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today the launch of Secure Barcode, a cloud-based application designed to enhance the security of customer physical communications through seamless barcode generation and insertion into documents.
-
INERATEC Opens ERA ONE: Europe's Largest e-Fuel Production Plant Goes Into Operation In Frankfurt6/3/2025
The German cleantech company INERATEC today officially inaugurated ERA ONE, a Power-to-Liquid plant for the production of e-Fuels and e-Chemicals that will usher in a new era of sustainable mobility.
-
Vioneo Appoints Wood To Design World's First Industrial Scale Fossil-Free Plastics Facility4/30/2025
Vioneo has awarded Wood, a global leader in consulting and engineering, a multi-million FEED contract to deliver the front-end engineering design for its revolutionary plant which will produce fossil-free plastics using green methanol.
-
PacBio Expands Partnership With seqWell To Bring Scalable Long Read Sample Prep To More Labs10/7/2025
PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions.